title: Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine.
authors.affiliation: Department of Urology and Renal Transplant, Hospital Clinic, University of Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Vilardell
authors.forename: F
authors.initials: F
authors.lastname: Oppenheimer
authors.forename: R
authors.initials: R
authors.lastname: Talbot-Wright
authors.forename: M J
authors.initials: MJ
authors.lastname: Ricart
authors.forename: J
authors.initials: J
authors.lastname: Andreu
authors.forename: A
authors.initials: A
authors.lastname: Alcaraz
authors.forename: P
authors.initials: P
authors.lastname: Carretero
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone